tradermen
Forumer storico
About Vicente Anido, Jr.
From 2001 to 2012, Dr. Anido was President, Chief Executive Officer and a Director of ISTA Pharmaceuticals, a US-based ophthalmic pharmaceutical company. Prior to this, he was general partner of Windamere Venture Partners, served as President and CEO of CombiChem, Inc., a biotechnology company, and was President of the Americas Region of Allergan, a specialty pharmaceutical company focusing on ophthalmology, dermatology and neuromuscular indications.
Dr. Anido currently serves on the Board of Directors of QLT Inc. and Depomed Inc., two NASDAQ-listed pharmaceutical companies, and was recently named Chairman of the Board of Directors of Aerie Pharmaceuticals, a US private ophthalmic company.
Dr. Anido received a B.S. in Pharmacy, an M.S. in Pharmacy Administration from West Virginia University and a Ph.D. in Pharmacy Administration from the University of Missouri.
Information on the 2013 Ordinary Shareholder Meeting is available on the Nicox internet website:
Nicox - Shareholder meetings.
From 2001 to 2012, Dr. Anido was President, Chief Executive Officer and a Director of ISTA Pharmaceuticals, a US-based ophthalmic pharmaceutical company. Prior to this, he was general partner of Windamere Venture Partners, served as President and CEO of CombiChem, Inc., a biotechnology company, and was President of the Americas Region of Allergan, a specialty pharmaceutical company focusing on ophthalmology, dermatology and neuromuscular indications.
Dr. Anido currently serves on the Board of Directors of QLT Inc. and Depomed Inc., two NASDAQ-listed pharmaceutical companies, and was recently named Chairman of the Board of Directors of Aerie Pharmaceuticals, a US private ophthalmic company.
Dr. Anido received a B.S. in Pharmacy, an M.S. in Pharmacy Administration from West Virginia University and a Ph.D. in Pharmacy Administration from the University of Missouri.
Information on the 2013 Ordinary Shareholder Meeting is available on the Nicox internet website:
Nicox - Shareholder meetings.